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Use of Sex-Specific Clinical and Exercise Risk Scores
to Identify Patients at Increased Risk for All-CauseMortality
Paul C. Cremer, MD; YupingWu, PhD; HaithamM. Ahmed, MD, MPH; LeeM. Pierson, MD;
Danielle M. Brennan, MS; Mouaz H. Al-Mallah, MD, MSc; Clinton A. Brawner, PhD; Jonathan K. Ehrman, PhD;
Steven J. Keteyian, PhD; Roger S. Blumenthal, MD; Michael J. Blaha, MD, MPH; Leslie Cho, MD
IMPORTANCE Risk assessment tools for exercise treadmill testing may have limited external
validity. Cardiovascular mortality has decreased in recent decades, and women have been
underrepresented in prior cohorts.
OBJECTIVES To determine whether exercise and clinical variables are associated with
differential mortality outcomes in men and women and to assess whether sex-specific risk
scores better estimate all-cause mortality.
DESIGN, SETTING, AND PARTICIPANTS This retrospective cohort study included 59877
patients seen at the Cleveland Clinic Foundation (CCF cohort) from January 1, 2000, through
December 31, 2010, and 49 278 patients seen at the Henry Ford Hospital (FIT cohort) from
January 1, 1991, through December 31, 2009. All patients were 18 years or older and
underwent exercise treadmill testing. Data were analyzed from January 1, 2000, to October
27, 2011, in the CCF cohort and from January 1, 1991, to April 1, 2013, in the FIT cohort.
MAIN OUTCOMES ANDMEASUREMENTS The CCF cohort was divided randomly into derivation
and validation samples, and separate risk scores were developed for men and women. Net
reclassification, C statistics, and integrated discrimination improvement were used to
compare the sex-specific risk scores with other tools that have all-cause mortality as the
outcome. Discrimination and calibration were also evaluated with these sex-specific risk
scores in the FIT cohort.
RESULTS The CCF cohort included 59877 patients (59.4%men; 40.5%women) with a
median (interquartile range [IQR]) age of 54 (45-63) years and 2521 deaths (4.2%) during a
median follow-up of 7 (IQR, 4.1-9.6) years. The FIT cohort included 49 278 patients (52.5%
men; 47.4%women) with a median (IQR) age of 54 (46-64) years and 6643 deaths (13.5%)
during a median (IQR) follow-up of 10.2 (7-13.4) years. C statistics for the sex-specific risk
scores in the CCF validation sample were higher (0.79 in women and 0.81 in men) than
C statistics using other tools in women (0.70 for Duke Treadmill Score; 0.74 for Lauer
nomogram) andmen (0.72 for Duke Treadmill Score; 0.75 for Lauer nomogram). Net
reclassification and integrated discrimination improvement were superior with the
sex-specific risk scores, mostly owing to correct reclassification of events. The sex-specific
risk scores in the FIT cohort demonstrated similar discrimination (C statistic, 0.78 for women
and 0.79 for men), and calibration was reasonable.
CONCLUSIONS AND RELEVANCE Sex-specific risk scores better estimatemortality in patients
undergoing exercise treadmill testing. In particular, these sex-specific risk scores help to
identify patients at the highest residual risk in the present era.
JAMA Cardiol. 2017;2(1):15-22. doi:10.1001/jamacardio.2016.3720
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Invited Commentary page 22
Supplemental content at
jamacardiology.com
Author Affiliations:Heart and
Vascular Institute, Cleveland Clinic,
Cleveland, Ohio (Cremer, Pierson,
Cho); Department of Mathematics,
Cleveland State University, Cleveland,
Ohio (Wu); Ciccarone Center for the
Prevention of Heart Disease, Johns
Hopkins Hospital, Baltimore,
Maryland (Ahmed, Blumenthal,
Blaha); C5 Research, Cleveland Clinic,
Cleveland, Ohio (Brennan); King
Abdulaziz Cardiac Center, King Saud
bin Abdulaziz University for Health
Sciences, King Abdullah International
Medical Research Center, Ministry of
National Guard, Health Affairs,
Riyadh, Saudia Arabia (Al-Mallah);
Division of Cardiovascular Medicine,
Henry Ford Hospital, Detroit,
Michigan (Al-Mallah, Brawner,
Ehrman, Keteyian).
Corresponding Author: Leslie Cho,
MD, Heart and Vascular Institute,
Cleveland Clinic, 9500 Euclid Ave,
Ste JB-1, Cleveland, OH 44124
(chol@ccf.org).
Research
JAMACardiology | Original Investigation
(Reprinted) 15
Downloaded From:  by a Cleveland State University Library User  on 01/05/2018
Copyright 2017 American Medical Association. All rights reserved.
E xercise testing is recommended to assess prognosis inpatients with known or suspected coronary artery dis-ease (CAD) who present with symptoms suggestive of
worsening ischemic heart disease.1 For nearly 3 decades, the
Duke Treadmill Score (DTS) has been the standard to assess
prognosis in thesepatients.2However, during thepast fewde-
cades, advances in therapyhavedramatically reduced cardio-
vascularmortality,3 and the validity of this score in a contem-
porary population is unclear. The DTS was also developed in
a predominantly male population, and a paucity of data re-
garding risk stratification with this score exists in women.4
Finally, the DTS incorporates only exercise duration,
ST-segment depression, and exercise-induced chest pain.2
Other exercise variables are associatedwith prognosis,5-7 and
manyof thesepatientshave cardiovascular comorbidities that
also affect their overall risk.
To address this latter concern, a nomogram was created
by Lauer and colleagues8 that is superior to the DTS at pre-
dicting all-causemortality. Thebroader clinical use of this no-
mogram is unclear and in part has been limited by exclusion
of certain patient populations, including those with known
CAD, valvular heart disease, heart failure, and end-stage re-
naldisease (ESRD).Furthermore, sex-relateddifferences in the
prognostic impact of exercise test variables and cardiovascu-
lar comorbidities should be accounted for.9,10 We therefore
aimed todevelopcomprehensive sex-specific risk scores toes-
timate all-causemortality in amore inclusive and contempo-
rary population. We then determined whether these sex-
specific risk scoresbetter estimatedmortalitywhencompared
with theDTSandLauernomogram.Finally,wevalidated these
sex-specific risk scores by assessing discrimination and cali-
bration in an external cohort.
Methods
Cleveland Clinic Cohort
From a cohort of 60 895 consecutive patients undergoing
symptom-limited treadmill testing at the Cleveland Clinic
Foundation (CCF) fromJanuary 1, 2000, toDecember31, 2010,
1018 were excluded owing to atrial fibrillation, a resting elec-
trocardiogram that precluded interpretation of the ST seg-
ment, digoxin use, being younger than 18 years, or having no
Social Security number available. The final CCF cohort in-
cluded 59877 patients.
At the time of stress testing, patient demographic charac-
teristics, comorbidities, and medications were prospectively
entered into a stress database. Known CAD was defined as a
previousmyocardial infarction, previous percutaneous coro-
nary intervention, or ahistoryof coronary arterybypass graft-
ing. Heart failurewas defined by self-reported history and re-
viewof themedical record.Hypertensionwasdefined as self-
reported history or use of antihypertensives. Hyperlipidemia
was defined as an abnormal fasting lipid panel according to
Adult Treatment Panel III guidelines, self-reportedhistory, or
use ofmedications to lower lipid levels. Diabeteswas defined
as a fasting blood glucose level of at least 126 mg/dL (to con-
vert tomillimoles per liter,multiply by 0.0555), self-reported
history, or use ofmedication to lower glucose levels. Patients
who were actively smoking cigarettes or who had smoked
within thepast yearwere consideredcurrent smokers, andpa-
tientswho had smoked less recentlywere considered to have
a history of smoking. We defined ESRD as receiving dialysis.
Patients underwent symptom-limited treadmill testing
using a protocol based on a pretest estimation of exercise ca-
pacity and designed to have the patient reach maximal exer-
tion within 8 to 12 minutes, as suggested by exercise testing
guidelines.1 Standard exercise protocolswere used, andmost
patientsperformedaBruceprotocol (61%).Otherprotocols in-
cluded Cornell, Naughton, modified Naughton, and modi-
fied Bruce.1 Heart rate targets were not used as an end point
or to judge the adequacyof the test. TheST segmentwasmea-
sured 80milliseconds after the J point, and themagnitude of
STdepressionwas recordedas thegreatesthorizontalordown-
sloping ST-segment depression in any lead except aVR dur-
ing the test or in recovery.
Blood pressure was measured during every stage of the
test.Heart ratewasrecordedfromanelectrocardiogramprinted
everyminuteduring the test.Peakestimatedmetabolicequiva-
lents of task (METs)were calculated from treadmill speed and
grade at peak exercise. Chest discomfort during the test was
recordedasnone,nonlimitingchestpain,or test-limitingchest
pain. Rate-pressure product (RPP)was calculated as theprod-
uct of heart rate and systolic blood pressure. A ΔRPPwas cal-
culated as RPP at peak exercise minus RPP at rest. Heart rate
recovery (HRR)was calculated as peak exercise heart ratemi-
nus heart rate at 1 minute after exercise.
Patients were given a standard walking recovery for tests
involving electrocardiography only, technetium imaging, or
metabolic stress testing. For patients undergoing stress ech-
ocardiography, a supine recovery immediately after exercise
was used. Therefore,HRRat 1minutewas classified as abnor-
mal if 12 or fewer beats/min for patients undergoing upright
recovery andabnormal if 18or fewer beats/min inpatientsun-
dergoing stress echocardiography.5,11,12 Chronotropic reserve
index was calculated as (Peak heart rate – resting heart rate)/
[(220 – age) – resting heart rate] and was considered abnor-
mal if no greater than 0.8 for patients not taking a β-blocker
and abnormal if at least 0.62 for patients taking a β-blocker.
In patients who did not undergo a Bruce protocol, the esti-
matedMETs achievedby eachpatientwere converted tomin-
utes per the Bruce protocol before calculation of the DTS.
Key Points
Question Do sex-specific risk scores better estimate all-cause
mortality for patients undergoing exercise treadmill testing?
Findings In a retrospective cohort study of nearly 110000
patients, sex-specific risk scores better estimatedmortality.
Exercise capacity had the greatest effect on prognosis in both
sexes, and all risk factors had a differential effect on prognosis in
women compared with men.
Meaning Risk stratification is improved with sex-specific risk
scores, and in particular, patients at the highest risk are more
readily identified.
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The DTS was calculated as Exercise time – (5 × maximum
ST-segment depression) – (4 × treadmill chest pain index).
Treadmill chest painwas scored from0 to2,with0 represent-
ing no chest pain; 1, nonlimiting chest pain; and 2, chest pain
for which the exercise test was terminated.2
Validation Cohort
The Henry Ford Exercise Testing (FIT) cohort is from a regis-
try of 69 885 consecutive patients who had physician-
referred exercise treadmill tests at the Henry Ford Health
System from January 1, 1991, through December 31, 2009.
Methodologic details have been reported previously.13 In
brief, patients older than 18 years who underwent exercise
treadmill tests were included. All testing used the standard
Bruce protocol. Exercise test, medical history, and medica-
tion data were collected at the time of testing, and support-
ing clinical data were derived from the electronic medical
record and administrative databases. For external validation
purposes, the 3880 patients without recorded weight and
the 16 727 without glomerular filtration rate data were
excluded. A final sample size of 49278 patients was included
for external validation.
All data in both cohorts were deidentified. The institu-
tional review boards at CCF, Henry Ford Health System, and
Johns Hopkins Hospital approved this study with an exemp-
tion for individual patient consent.
Outcome
The primary outcomewas all-causemortality andwas deter-
mined from the Social Security Death IndexMaster File. Pre-
viouswork14demonstrated thatmore than95%of the time the
Social Security Death Index correctly identifies patients who
have died. The final censoring date was October 27, 2011, in
the CCF cohort, and April 1, 2013, in the FIT cohort.
Statistical Analysis
Datawere analyzed fromJanuary 1, 2000, toOctober 27, 2011,
in the CCF cohort and from January 1, 1991, to April 1, 2013, in
the FIT cohort. For men and women, the CCF sample was di-
vided randomly, with 50% of patients in the derivation co-
hort and 50% in the validation cohort. All data analysis to de-
velop risk scoreswasperformed in thederivationcohorts.Data
are summarized as median and interquartile range (IQR) for
continuousdata andnumber (percentage) of nonmissingdata
forcategoricalvariables.Comparisonsacrossagecategoriesand
survival status used 2-tailed unpaired t tests for continuous
variables and χ2 tests for categorical variables. Cox propor-
tional hazards regression models were used to create sepa-
rate multivariable models for men and women to determine
independent risk factors for all-cause mortality.
All variables that were significantly associated with all-
causemortality onunivariable analysis (P < .05)were consid-
ered for multivariable adjustment. Bootstrapping methods
were used to identify variables for inclusion in the finalmod-
els.Twohundredbootstrappedmodelsweregeneratedformen
andwomen;variables thatwereentered into themodelsat least
50% of the time were then entered into a backward stepwise
selectionmodeling process to create separate Coxmodels for
men and women. These Cox models were validated for cali-
bration accuracy to estimate overall survival (eMethods in the
Supplement).
TheCoxmodels fromthederivationcohortwere thenused
todevelop sex-specific risk scores for estimatingmortality. To
assign value to each variable in creating a risk score, catego-
ries were created for the continuous variables in the model.
Creation of these categories was based on the distribution of
eachvariable.Linearitywas testedwithrestrictedcubicsplines.
Continuous variableswere divided into quartileswith the ex-
ception of age for women and weight for men. The β coeffi-
cients across quartiles were similar for these variables; thus,
age forwomenwasdivided into older than65yearsor65years
or younger, and weight for men was divided into more than
80 kg or 80 kg or less. The β coefficients of each covariate in
these categorieswere thenused to assignpoints for every risk
factor (eMethods in the Supplement). The points were then
added together toobtain a total score.Overall, 7%ofdatawere
missing. To reduce bias in estimates and uncertainty related
to the imputationmodel,multiple imputationofmissingvari-
ables was performed with a regression-based method. In the
CCF validation cohorts, discrimination was assessedwith re-
ceiver operating characteristic curves andHarrell C statistics,
category-free net reclassification improvement, and inte-
grated discrimination improvement.15
TheFITcohort servedasanexternalvalidationcohort.The
risk scoresweremodifiedbecause certaindatawerenot avail-
able in both cohorts. Heart rate recovery was not available in
theFITdatabase andwasexcluded fromthemodelsusing this
cohort. A history of smoking was not available in the FIT co-
hort andwas replacedwithcurrent smoking.Finally,ESRDwas
not categorized in theFIT cohort andwas replacedbyglomer-
ular filtration rate of less than 15mL/min/1.73m2.Discrimina-
tion with these modifications to the risk scores was assessed
with receiver operating characteristic curves andHarrell C sta-
tistics.Calibrationwasassessedbydividing the risk scores into
deciles for men and women and plotting observed vs pre-
dicted mortality.
All analyseswereperformedusingSAS (version9.2;SAS In-
stitute Inc), R (R CoreTeam2015 [http://www.R-project.org/]),
and STATA (version 14.0; StataCorp) statistical software. Two-
tailed P < .05 was considered statistically significant.
Results
Patient Characteristics
Owing to known differences in the prevalence and impact of
comorbidities and exercise variables between men and
women,10 the 59877 patients in the CCF cohort were divided
by sex (59.4% men; 40.5% women) for all analyses. Overall,
the median age was 54 (IQR, 45-63) years, and 66.4% of the
populationwaswhite.Cardiovascularcomorbiditiesweremore
common inmen, especially a history of CAD (24.2%vs9.2%).
Exercisecapacitywasgenerallypreserved,andmenhadhigher
exercise capacity (10 [IQR, 8.3-11.5] vs 8 [IQR, 6.6-10] METs)
andDTSs (8.5 [IQR,5.5-10.2]vs6.5 [IQR,4-8.2]) comparedwith
women (Table 1). In the FIT cohort (52.5% men; 47.4%
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women), themedian (IQR)agewasalso54 (46-64)years,63.9%
were white, and cardiovascular comorbidities were common
(eTable 1 in the Supplement).
Univariable AssociationsWith IncreasedMortality
In the CCF cohort, during a median follow-up of 7 (IQR, 4.1-
9.6) years, 2521 deaths occurred (4.2% mortality), with 742
deaths inwomen (3.1%mortality) and 1779deaths inmen (5%
mortality). In both sexes, death was associated with in-
creased age, lower body weight, diabetes, hypertension, hy-
perlipidemia, current or former smoking, CAD,myocardial in-
farction,percutaneous coronary intervention, coronaryartery
bypassgrafting, chronicobstructivepulmonarydisease, stroke
or transient ischemic attack, heart failure, ESRD, and periph-
Table 1. Baseline Clinical, Medication, and Exercise Data for the CCF Cohort
Data
CCF Cohort, No. (%)
P Value
Overall
(n = 59 877)
Women
(n = 24 292)
Men
(n = 35 585)
Clinical
Age, median (IQR), y 54 (45-63) 53 (45-62) 54 (45-63) .007
White race 39 753 (66.4) 15 201 (62.6) 24 552 (69) <.001
BMI, median (IQR) 28 (24.9-31.7) 27.5 (23.7-32.2) 28.2 (25.6-31.4) <.001
Body weight, median (IQR), kg 84 (72-97) 73 (63-86) 89 (80-101) <.001
Diabetes 6924 (11.6) 2635 (10.8) 4289 (21.1) <.001
Hypertension 27 142 (45.3) 10 610 (43.7) 16 532 (46.4) <.001
Hyperlipidemia 31 594 (52.8) 11 610 (47.8) 19 984 (56.2) <.001
History of smoking 26 894 (44.9) 9735 (40.1) 17 159 (48.2) <.001
Current smoker 7361 (12.3) 2988 (12.3) 4373 (12.3) .82
Family history of CAD 19 927 (33.3) 8655 (35.6) 11 272 (31.7) <.001
CAD 10 855 (18.1) 2225 (9.2) 8630 (24.2) <.001
Previous
MI 4766 (8) 957 (3.9) 3809 (10.7) <.001
PCI 4370 (7.3) 853 (3.5) 3517 (9.9) <.001
CABG 3181 (5.3) 466 (1.9) 2715 (7.6) <.001
COPD 900 (1.5) 349 (1.4) 551 (1.5) .14
Stroke or TIA 1350 (2.3) 532 (2.2) 818 (2.3) .17
CHF 918 (1.5) 333 (1.4) 585 (1.6) .002
ESRD 264 (0.4) 84 (0.3) 180 (0.5) .002
PVD 684 (1.1) 221 (0.9) 463 (1.3) <.001
Medications
Aspirin 22 692 (37.9) 7228 (29.8) 15 464 (43.4) <.001
Clopidogrel 3339 (5.6) 856 (3.5) 2483 (7) <.001
β-Blocker 14 848 (24.8) 5683 (23.4) 9165 (25.8) <.001
ACEI or ARB 14 964 (25) 5110 (21) 9854 (27.7) <.001
Statin 18 990 (31.7) 5950 (24.5) 13 040 (36.6) <.001
Exercise data
Rest
Heart rate, median (IQR),
beats/min
69 (62-78) 73 (65-82) 67 (60-76) <.001
Systolic BP, median (IQR),
mm Hg
128 (118-140) 126 (112-140) 130 (118-142) <.001
RPPa 8.9 (7.6-10.5) 9.2 (7.8-10.8) 8.7 (7.4-10.2) <.001
No ST depression 47 444 (79.2) 19 628 (81) 27 816 (78.2) <.001
Chest pain 1623 (2.7) 552 (2.3) 1071 (3) <.001
Termination owing to chest pain 927 (1.5) 362 (1.5) 565 (1.6) .36
Maximum heart rate, median
(IQR), beats/min
157 (144-171) 157 (144-170) 159 (144-171) <.001
Maximum RPP, median (IQR)a 28.1 (24.2-31.8) 26.8 (23.3-30.3) 29 (25-32.8) <.001
Maximum ΔRPP, median (IQR)b 18.8 (14.9-22.6) 17.3 (13.9-20.6) 20.1 (16-23.7) <.001
Peak METs, median (IQR) 9.3 (7.2-11) 8 (6.6-10) 10 (8.3-11.5) <.001
Abnormal HRRc 9704 (16.2) 3948 (16.3) 5756 (16.2) .81
Abnormal CRId 11 156 (18.6) 4993 (20.6) 6163 (17.3) <.001
DTS, median (IQR) 7.5 (4.5-9.5) 6.5 (4-8.2) 8.5 (5.5-10.2) <.001
Abbreviations: ACEI, angiotension
converting enzyme inhibitor;
ARB, angiotension receptor blocker;
BMI, bodymass index (calculated as
weight in kilograms divided by height
in meters squared); BP, blood
pressure; CABG, coronary artery
bypass graft; CAD, coronary artery
disease; CCF, Cleveland Clinic
Foundation; CHF, congestive heart
failure; COPD, chronic obstructive
pulmonary disease; CRI, chronotropic
response index; DTS, Duke Treadmill
Score; ESRD, end-stage renal disease;
HRR, heart rate recovery;
IQR, interquartile range;
METs, estimatedmetabolic
equivalents; MI, myocardial
infarction; PCI, percutaneous
coronary intervention;
PVD, peripheral vascular disease;
RPP, rate-pressure product;
TIA, transient ischemic attack.
a Calculated as (heart rate × systolic
BP)/1000.
bCalculated as maximal RPPminus
resting RPP.
c Calculated as peak exercise heart
rate minus heart rate at 1 minute
after exercise.
d Calculated as (peak heart
rate − resting heart
rate)/[(220 − age) − resting heart
rate].
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eral arterial disease. Inmen, deathwas also associatedwith a
lower body mass index and a family history of coronary dis-
ease. With regard to exercise variables, death was associated
with ST-segmentdepression, lowermaximal heart rate, lower
maximal RPP and ΔRPP, lower peakMETs, an abnormal HRR,
andanabnormal chronotropic reserve index.A lowerDTSwas
alsoassociatedwith increasedmortality,butnoassociationwas
foundbetweennonlimiting or limiting chest pain andmortal-
ity (eTable 2 in the Supplement).
Developing the Sex-Specific Risk Scores
Inmultivariable Coxmodels, lower peak estimatedMETs, ab-
normalHRR, increasingage, lowerbodyweight, currentor for-
mer smoking, and ESRDwere all associatedwithmortality in
men and women (eTable 3 in the Supplement). In addition, a
history of diabetes was associated with mortality in women,
whereas a history of heart failure and hypertension were as-
sociatedwithmortality inmen.TheseCoxmodelsshowedgood
calibration at predictingmortality at 10 years (eFigure 1 in the
Supplement). The β coefficients from these Cox proportional
hazards regressionmodelswere thenused to assignpoints for
each covariate (Table 2). The final risk scores for women and
menshowedhighdiscrimination inestimatingmortality in the
derivation cohorts (C statistic for women, 0.82; C statistic for
men, 0.81).
Kaplan-Meier Survival Analysis
Although the DTS was associated with mortality when as-
sessedas a continuousvariable, differentiationof riskwas lim-
itedwhenassessed according to the typical DTS categories. In
particular, fewpatientshadhigh-riskDTSs that resulted inwide
andoverlapping95%CIs. Similar resultswereobtained inmen
andwomen (Figure 1A and C). Of note, 78 women (0.3%) and
221men(0.6%)hadhigh-riskDTSs.Conversely, survival curves
using the sex-specific risk scores effectively identified pa-
tients at highest risk for all-causemortality (Figure 1B andD),
as is also evident in the estimate of 10-year mortality risk ac-
cording to the sex-specific risk scores (eTables 4 and 5 in the
Supplement).
Validating the Risk Scores
For the sex-specific risk scores, C statisticswere similar in the
CCF validation cohorts (0.79 for women and 0.81 for men).
These sex-specific risk scores also performed better at esti-
mating mortality when compared with the other models in
women (C statistic for DTS, 0.70; C statistic for Lauer nomo-
gram,0.74) (eFigure 2A in the Supplement) and inmen (C sta-
tistic forDTS,0.72;C statistic forLauernomogram,0.75) (eFig-
ure 2B in the Supplement). Category-free net reclassification
improvementandintegrateddiscrimination improvementwere
also significantly improved with the sex-specific risk scores
when compared with the DTS and the Lauer nomogram
(Table 3). This improved discrimination primarily corre-
sponded to the correct reclassification of patients who died.
Finally, sex-specific risk scores were calculated for pa-
tients in the FIT cohort to assess external validation. At ame-
dian follow-upof 10.2years, therewere6643deaths inapopu-
lationof49278 (13.5%).TheCstatistics for the sex-specific risk
scores were similar in women (0.78) andmen (0.79). Regard-
ing calibration, good tracking of observed vs predicted mor-
tality was found (Figure 2).
Discussion
The present study is, to our knowledge, the largest to date to
developsex-specificprognostic risk scoresusing treadmill test-
ing data.Wehavedemonstrated excellent discrimination and
calibration for estimatingmortality in the CCFderivation and
validation cohorts. Moreover, in the CCF validation cohort,
C statistics, net reclassification improvement, and integrated
discrimination improvementwith thesenewsex-specific risk
scores were improved compared with the DTS and Lauer no-
mogram.Finally, discriminationandcalibrationwere also rea-
sonable when the sex-specific risk scores were tested exter-
nally in the FIT cohort.
A few important observations from our study should be
highlighted.First, inpatientsundergoing treadmill testing,our
Table 2. Sex-Specific Exercise and Clinical Risk Scores
for EstimatingMortality
Variable Points
Women
Peak treadmill METs
<5 10
5-7 8
7-10 4
ESRD 5
Weight, kg
<50 4
50-70 3
70-90 2
Age >65 y 1
Abnormal HRR 2
Former/current smoking 2
Diabetes 1
Men
Peak treadmill METs
<8 10
8-10 6
10-12 4
ESRD 7
Weight <80 kg 1
Age, y
55-65 1
65-75 4
>75 7
Abnormal HRR 3
Former/current smoking 1
History
Hypertension 2
Heart failure 5
Abbreviations: ESRD, end-stage renal disease; HRR, heart rate recovery;
METs, metabolic equivalents.
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data support separate risk scoresaccording to sex.Certainvari-
ables are present or absent in the models for men vs women,
and the hazard ratios for risk factors common to bothmodels
differ according to sex. Therefore, rather than simply adjust-
ing for sex,wearguethatasex-specificapproachshouldbecon-
sidered when assessing the prognosis for patients who un-
dergo exercise testing. In addition, although many variables
are associatedwithmortality and refine risk stratification, de-
creased exercise capacity is themost important risk factor for
men and women. Finally, as shown in our category-free net
reclassification improvement, themajor advantageof our risk
scores is the identification of patientswho are likely to have a
fatal event. As cardiovascularmortality continues todecline,3
identification of patients with the highest residual risk is in-
creasingly important.
Previous Studies
The DTS remains the most common method to assess prog-
nosis inpatientswith exercise testing, although this scorewas
developed in higher-risk patients—predominantly middle-
aged men—who all had chest pain and invasive coronary
angiography.2 In a lower-risk andmore diverse patient popu-
lation, our studydemonstrates that theprognostic valueof the
DTS is related solely to the importance of exercise capacity.
Chest pain and ST depression with exertion were not associ-
Table 3. Discrimination Analysis for the CCF Cohort Comparing
the NRSsWith the DTS and Lauer Nomogram inWomen andMen
Discrimination Analysis
% (95% CI)
Women Men
IDI: NRSs vs DTS 20 (18.7-21.3) 19 (18.2-19.8)
Category-free NRI
NRSs vs DTS 75.8 (68.1-83.6) 81.6 (76.3-86.8)
Events correctly reclassified 66.5 (58.9-74) 63.2 (58.1-68.2)
Nonevents correctly reclassified 9.4 (7.5-11.2) 18.4 (16.9-19.9)
IDI: NRSs vs Lauer nomogram 23 (21.7-24.4) 24 (23.2-24.8)
Category-free NRI
NRSs vs Lauer nomogram 80.1 (72.6-87.6) 87.3 (82.5-92)
Events correctly reclassified 69.2 (61.9-76.5) 72 (67.5-76.5)
Nonevents correctly reclassified 10.9 (9.1-12.7) 15.3 (13.8-16.8)
Abbreviations: CCF, Cleveland Clinic Foundation; DTS, Duke Treadmill Score;
IDI, integrated discrimination improvement; NRI, net reclassification
improvement; NRSs, sex-specific new risk scores.
Figure 1. Kaplan-Meier Survival Analysis forWomen andMen in the Cleveland Clinic Foundation (CCF) Cohort
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The CCF cohort included 24 292 women and 35 585men. Data points indicate median; error bars, 95% CI. Duke Treadmill Scores are stratified as low, intermediate,
and high risk. The sex-specific risk scores are stratified into tertiles.
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ated with mortality in multivariable models. The Lauer no-
mogram improved on the DTS by incorporating other exer-
cise variables and comorbidities.8 However, notable patient
populationswere excluded. Our objectivewas to createmore
comprehensive risk scoreswithamore inclusivepatientpopu-
lation. This approach facilitates a broader clinical use for our
sex-specific risk scores.
Limitations
Our study has several notable limitations. First, we assessed
all-cause instead of cardiac death, although all-cause mor-
tality may be preferred because it is an unbiased end point.
Second, imaging data were not included in our analysis and
have been shown to have prognostic importance.16,17 How-
ever, the focus of this study was to develop risk scores
based on clinical and exercise variables alone. Third, all
patients in the study underwent evaluation at large referral
centers, and generalizability to smaller hospitals may be
limited. Finally, because of differences in data collection,
the risk scores tested in the FIT cohort were similar, but not
identical, to the scores used in the CCF cohort. Discrimina-
tion was good in both cohorts, but this observation should
not lead to the exclusion of certain variables in risk assess-
ment, especially because HRR has emerged as a risk factor
in several studies.7,11,12,18 In fact, in a well-developed model,
little change may occur in the C statistic when an additional
variable is added, even if that variable improves risk
stratification.19
Conclusions
In a large cohort of patients who underwent treadmill test-
ing,wehavedemonstratedadifferential effectof exercisevari-
ables and clinical risk factors onoverallmortality according to
sex.Thesex-specific riskscoresoutperformprevious riskstrati-
fication tools and help to identify patients at the highest risk
for death. To facilitate clinical use of these sex-specific risk
scores,wehavedevelopedanonline calculator to estimate 10-
year mortality (http://www.clevelandclinic.org/lp/hvi-tools
/10YearMortality.html). Even when accounting for multiple
comorbidities, exercise capacitywas still thepredominant risk
factor inmen andwomen. This online calculator can be used
byphysiciansandpatients tonotonlyassessprognosisbutalso
emphasize the importance of exercise, even in the presence
of other cardiovascular risk factors.
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Invited Commentary
CanWe ImproveMortality Estimation inWomen
After Treadmill Testing by Using Sex-Specific Scores?
Ashok Krishnaswami, MD, MAS; Jeff W. Christle, MA; Victor Froelicher, MD
The use of predictive analytics in modern cardiology has
had a significant impact in decreasing the subjectivity of
forecasting cardiovascular events. The abundance of cur-
rently available clinical pre-
diction models (CPMs) has
been demonstrated by a
recent systematic review.1
This review unearthed 796 scientific articles on the topic of
CPMs and cardiovascular disease published from 1990 to
2012, with 90% being novel and the remainder recalibration
or other adaptations of prior CPMs. Although utilization of
CPMs is currently low, it promises to decrease use of the rou-
tine subjective eyeball test.2
To establish an anatomical diagnosis of coronary artery
disease and to estimate the probability of future cardiac
events is a difficult task. This concept is not dissimilar to the
Heisenberg “uncertainty principle” in which a particle’s
position and momentum cannot be known with complete
precision.3 Therefore, working in this arena requires an
acceptance of some uncertainty. The exercise treadmill test
has been recommended as a routine first-line test for indi-
viduals capable of exercising with no contraindications and
without an abnormal resting electrocardiographic finding.4
However, concern about its low sensitivity and specificity
(leading to false-positive findings), owing to an undue focus
on the ST segment often results in the use of additional
imaging modalities (myocardial perfusion or echocardiogra-
phy). Advanced CPMs have come to the rescue and have
been shown to be superior to subjective prognostication.5
They have improved the accuracy of diagnosis of coronary
artery disease and the prognosis of future cardiovascular
events, reduced costs, and aided the decision-making
process.6,7
In this issue of JAMA Cardiology, Cremer et al8 have tied
together 3 important areas in cardiovascular medicine: the
use of CPMs, sex-specific research,9 and treadmill testing.
The investigators used the Cleveland Clinic Foundation
(CCF) cohort for derivation and internal validation and the
Henry Ford Exercise Testing (FIT) cohort for external valida-
tion. The study examined the hypothesis that sex-specific
CPMs are superior to general models that have been risk
adjusted for sex, such as the Lauer score.10 The models were
tested using standard discrimination and calibration statis-
tics. Patients in the CCF cohort underwent symptom-limited
treadmill testing using multiple treadmill protocols. Comor-
bidities were obtained at the time of the baseline treadmill
test. Subsequent prognostic variables, such as the Duke
Treadmill Score, chronotropic reserve index, and rate-
pressure product, were then calculated using standard
treadmill variables that were also obtained at the time of
baseline testing. The primary outcome of all-cause mortality
was determined by the Social Security Death Index Master
File. Covariate β coefficients were obtained using time-to-
event analysis (Cox proportional hazards regression model)
with a backward-stepwise covariate selection that was sub-
sequently used to develop a linear score.
The study findings demonstrated that the women re-
ferred for exercise testingwereyounger,were lessoftenwhite,
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